ANC 0 3 0 3 B-clinical_variable
≥1.5 4 8 4 8 O
x 9 10 9 10 I-lower_bound
10 11 13 11 13 I-lower_bound
^ 13 14 13 14 I-lower_bound
9 14 15 14 15 I-lower_bound
/ 15 16 15 16 I-lower_bound
L 16 17 16 17 I-lower_bound

AST 0 3 18 21 B-clinical_variable
and 4 7 22 25 O
ALT 8 11 26 29 B-clinical_variable
≤3× 12 15 30 33 O
ULN 16 19 34 37 I-upper_bound
or 20 22 38 40 O
< 23 24 41 42 O
5 25 26 43 44 B-upper_bound
ULN 27 30 45 48 I-upper_bound
for 31 34 49 52 O
patients 35 43 53 61 O
with 44 48 62 66 O
liver 49 54 67 72 B-cancer
metastases 55 65 73 83 I-cancer

AST 0 3 84 87 B-clinical_variable
and 4 7 88 91 I-clinical_variable
ALT 8 11 92 95 I-clinical_variable
≤3× 12 15 96 99 O
ULN 16 19 100 103 I-upper_bound
or 20 22 104 106 O
≤ 23 24 107 108 O
5 25 26 109 110 B-upper_bound
x 27 28 111 112 I-upper_bound
ULN 29 32 113 116 I-upper_bound
for 33 36 117 120 O
patients 37 45 121 129 O
with 46 50 130 134 O
liver 51 56 135 140 B-cancer
metastases 57 67 141 151 I-cancer

Acute 0 5 152 157 O
or 6 8 158 160 O
currently 9 18 161 170 O
active 19 25 171 177 O
hepatic 26 33 178 185 B-chronic_disease
or 34 36 186 188 O
biliary 37 44 189 196 B-chronic_disease
disease 45 52 197 204 I-chronic_disease
requiring 53 62 205 214 O
antiviral 63 72 215 224 B-treatment
therapy 73 80 225 232 I-treatment

Acute 0 5 233 238 O
or 6 8 239 241 O
currently 9 18 242 251 O
active 19 25 252 258 O
/ 25 26 258 259 O
requiring 26 35 259 268 O
antiviral 36 45 269 278 B-treatment
therapy 46 53 279 286 I-treatment
hepatic 54 61 287 294 B-chronic_disease
or 62 64 295 297 O
biliary 65 72 298 305 B-chronic_disease
disease 73 80 306 313 I-chronic_disease

Adequate 0 8 314 322 O
organ 9 14 323 328 O
function 15 23 329 337 O
as 24 26 338 340 O
defined 27 34 341 348 O
below 35 40 349 354 O
within 41 47 355 361 O
2 48 49 362 363 B-upper_bound
weeks 50 55 364 369 I-upper_bound
of 56 58 370 372 O
registration 59 71 373 385 O

Adequate 0 8 386 394 O
organ 9 14 395 400 O
function 15 23 401 409 O
as 24 26 410 412 O
defined 27 34 413 420 O
below 35 40 421 426 O
within 41 47 427 433 O
8 48 49 434 435 B-upper_bound
weeks 50 55 436 441 I-upper_bound
of 56 58 442 444 O
pre 59 62 445 448 O
- 62 63 448 449 O
registration 63 75 449 461 O

Agree 0 5 462 467 O
to 6 8 468 470 O
provide 9 16 471 478 O
archival 17 25 479 487 O
tumor 26 31 488 493 B-cancer
material 32 40 494 502 O
for 41 44 503 506 O
research 45 53 507 515 O

At 0 2 516 518 O
least 3 8 519 524 O
18 9 11 525 527 B-lower_bound
years 12 17 528 533 I-lower_bound
of 18 20 534 536 O
age 21 24 537 540 B-age

Currently 0 9 541 550 O
receiving 10 19 551 560 O
any 20 23 561 564 O
other 24 29 565 570 O
investigational 30 45 571 586 B-treatment
agents 46 52 587 593 I-treatment
or 53 55 594 596 O
systemic 56 64 597 605 B-treatment
cancer 65 71 606 612 I-treatment
therapy 72 79 613 620 I-treatment

Currently 0 9 621 630 O
taking 10 16 631 637 O
medications 17 28 638 649 O
and 29 32 650 653 O
herbal 33 39 654 660 O
or 40 42 661 663 O
dietary 43 50 664 671 O
supplements 51 62 672 683 O
that 63 67 684 688 O
are 68 71 689 692 O
strong 72 78 693 699 O
cytochrome 79 89 700 710 O
P450 90 94 711 715 B-treatment
( 95 96 716 717 I-treatment
CYP 96 99 717 720 I-treatment
) 99 100 720 721 I-treatment
3A4 101 104 722 725 I-treatment
inducers 105 113 726 734 I-treatment
or 114 116 735 737 O
inhibitors 117 127 738 748 B-treatment

ECOG 0 4 749 753 B-clinical_variable
performance 5 16 754 765 I-clinical_variable
status 17 23 766 772 I-clinical_variable
≤ 24 25 773 774 O
2 26 27 775 776 B-upper_bound

ECOG 0 4 777 781 B-clinical_variable
performance 5 16 782 793 I-clinical_variable
status 17 23 794 800 I-clinical_variable
≤2 24 26 801 803 O

ER 0 2 804 806 B-clinical_variable
and/or 3 9 807 813 O
PR 10 12 814 816 B-clinical_variable
positivity 13 23 817 827 O
by 24 26 828 830 O
institutional 27 40 831 844 O
standard 41 49 845 853 O
is 50 52 854 856 O
required 53 61 857 865 O
on 62 64 866 868 O
pathology 65 74 869 878 O
from 75 79 879 883 O
the 80 83 884 887 O
most 84 88 888 892 O
recent 89 95 893 899 O
tumor 96 101 900 905 B-cancer
specimen 102 110 906 914 O
unless 111 117 915 921 O
the 118 121 922 925 O
tissue 122 128 926 932 O
source 129 135 933 939 O
( 136 137 940 941 O
for 137 140 941 944 O
example 141 148 945 952 O
, 148 149 952 953 O
pleural 150 157 954 961 O
effusion 158 166 962 970 O
or 167 169 971 973 O
ascites 170 177 974 981 O
or 178 180 982 984 O
bone 181 185 985 989 B-treatment
biopsy 186 192 990 996 I-treatment
) 192 193 996 997 O
may 194 197 998 1001 O
yield 198 203 1002 1007 O
false 204 209 1008 1013 O
negative 210 218 1014 1022 O
ER 219 221 1023 1025 O
and/or 222 228 1026 1032 O
PR 229 231 1033 1035 O
result 232 238 1036 1042 O
, 238 239 1042 1043 O
in 240 242 1044 1046 O
which 243 248 1047 1052 O
case 249 253 1053 1057 O
the 254 257 1058 1061 O
pathology 258 267 1062 1071 O
from 268 272 1072 1076 O
an 273 275 1077 1079 O
earlier 276 283 1080 1087 O
time 284 288 1088 1092 O
point 289 294 1093 1098 O
could 295 300 1099 1104 O
be 301 303 1105 1107 O
used 304 308 1108 1112 O
and 309 312 1113 1116 O
a 313 314 1117 1118 O
discussion 315 325 1119 1129 O
with 326 330 1130 1134 O
the 331 334 1135 1138 O
study 335 340 1139 1144 O
chair 341 346 1145 1150 O
is 347 349 1151 1153 O
required 350 358 1154 1162 O

Experiencing 0 12 1163 1175 O
grade 13 18 1176 1181 B-lower_bound
2 19 20 1182 1183 I-lower_bound
or 21 23 1184 1186 O
greater 24 31 1187 1194 O
diarrhea 32 40 1195 1203 B-chronic_disease

HER2 0 4 1204 1208 B-cancer
mutations 5 14 1209 1218 I-cancer
detected 15 23 1219 1227 O
by 24 26 1228 1230 O
Guardant360 27 38 1231 1242 B-treatment

Histologically 0 14 1243 1257 O
or 15 17 1258 1260 O
cytologically 18 31 1261 1274 O
confirmed 32 41 1275 1284 O
HER2 42 46 1285 1289 B-cancer
- 46 47 1289 1290 O
negative 47 55 1290 1298 O
( 56 57 1299 1300 O
0 57 58 1300 1301 O
or 59 61 1302 1304 O
1 62 63 1305 1306 O
+ 63 64 1306 1307 O
by 65 67 1308 1310 O
IHC 68 71 1311 1314 O
or 72 74 1315 1317 O
non 75 78 1318 1321 O
- 78 79 1321 1322 O
amplified 79 88 1322 1331 O
by 89 91 1332 1334 O
FISH 92 96 1335 1339 O
) 96 97 1339 1340 O
breast 98 104 1341 1347 B-cancer
cancer 105 111 1348 1354 I-cancer
that 112 116 1355 1359 O
is 117 119 1360 1362 O
stage 120 125 1363 1368 O
IV 126 128 1369 1371 O

History 0 7 1372 1379 O
of 8 10 1380 1382 O
significant 11 22 1383 1394 O
cardiac 23 30 1395 1402 B-chronic_disease
disease 31 38 1403 1410 I-chronic_disease
, 38 39 1410 1411 O
cardiac 40 47 1412 1419 B-chronic_disease
risk 48 52 1420 1424 I-chronic_disease
factors 53 60 1425 1432 I-chronic_disease
, 60 61 1432 1433 O
or 62 64 1434 1436 O
uncontrolled 65 77 1437 1449 O
arrhythmias 78 89 1450 1461 B-chronic_disease

LVEF 0 4 1462 1466 B-clinical_variable
> 5 6 1467 1468 O
or 7 9 1469 1471 O
= 10 11 1472 1473 O
institutional 12 25 1474 1487 B-clinical_variable
ILLN 26 30 1488 1492 I-clinical_variable
within 31 37 1493 1499 O
4 38 39 1500 1501 B-upper_bound
weeks 40 45 1502 1507 I-upper_bound
of 46 48 1508 1510 O
registration 49 61 1511 1523 O

Men 0 3 1524 1527 B-gender
must 4 8 1528 1532 O
agree 9 14 1533 1538 B-contraception_consent
and 15 18 1539 1542 I-contraception_consent
commit 19 25 1543 1549 I-contraception_consent
to 26 28 1550 1552 I-contraception_consent
use 29 32 1553 1556 I-contraception_consent
a 33 34 1557 1558 I-contraception_consent
barrier 35 42 1559 1566 I-contraception_consent
method 43 49 1567 1573 I-contraception_consent
of 50 52 1574 1576 I-contraception_consent
contraception 53 66 1577 1590 I-contraception_consent
while 67 72 1591 1596 O
on 73 75 1597 1599 O
treatment 76 85 1600 1609 B-treatment
and 86 89 1610 1613 O
for 90 93 1614 1617 O
3 94 95 1618 1619 B-lower_bound
months 96 102 1620 1626 I-lower_bound
after 103 108 1627 1632 O
the 109 112 1633 1636 O
last 113 117 1637 1641 O
dose 118 122 1642 1646 O
of 123 125 1647 1649 O
the 126 129 1650 1653 O
investigational 130 145 1654 1669 O
product 146 153 1670 1677 O

Patients 0 8 1678 1686 O
with 9 13 1687 1691 O
known 14 19 1692 1697 O
brain 20 25 1698 1703 B-cancer
metastasis 26 36 1704 1714 I-cancer
are 37 40 1715 1718 O
eligible 41 49 1719 1727 O
, 49 50 1727 1728 O
but 51 54 1729 1732 O
must 55 59 1733 1737 O
have 60 64 1738 1742 O
received 65 73 1743 1751 O
radiation 74 83 1752 1761 B-treatment
and 84 87 1762 1765 O
be 88 90 1766 1768 O
off 91 94 1769 1772 O
steroids 95 103 1773 1781 B-treatment
and 104 107 1782 1785 O
stable 108 114 1786 1792 O
( 115 116 1793 1794 O
without 116 123 1794 1801 O
evidence 124 132 1802 1810 O
of 133 135 1811 1813 O
disease 136 143 1814 1821 O
progression 144 155 1822 1833 O
by 156 158 1834 1836 O
imaging 159 166 1837 1844 O
or 167 169 1845 1847 O
exam 170 174 1848 1852 O
) 174 175 1852 1853 O
for 176 179 1854 1857 O
3 180 181 1858 1859 B-upper_bound
months 182 188 1860 1866 I-upper_bound

Platelet 0 8 1867 1875 B-clinical_variable
count 9 14 1876 1881 I-clinical_variable
≥100 15 19 1882 1886 O
x 20 21 1887 1888 I-lower_bound
10 22 24 1889 1891 I-lower_bound
^ 24 25 1891 1892 I-lower_bound
9 25 26 1892 1893 I-lower_bound
/ 26 27 1893 1894 I-lower_bound
L 27 28 1894 1895 I-lower_bound

Pregnant 0 8 1896 1904 B-pregnancy

Prior 0 5 1905 1910 B-treatment
treatment 6 15 1911 1920 I-treatment
with 16 20 1921 1925 I-treatment
neratinib 21 30 1926 1935 I-treatment

QTc 0 3 1936 1939 B-clinical_variable
interval 4 12 1940 1948 I-clinical_variable
≤450 13 17 1949 1953 O
msec 18 22 1954 1958 I-upper_bound
for 23 26 1959 1962 O
men 27 30 1963 1966 B-gender
or 31 33 1967 1969 O
< 34 35 1970 1971 O
or 36 38 1972 1974 O
≤ 39 40 1975 1976 O
470 41 44 1977 1980 B-upper_bound
msec 45 49 1981 1985 I-upper_bound
for 50 53 1986 1989 O
women 54 59 1990 1995 B-gender
within 60 66 1996 2002 O
2 67 68 2003 2004 B-upper_bound
weeks 69 74 2005 2010 I-upper_bound
of 75 77 2011 2013 O
registration 78 90 2014 2026 O

Serum 0 5 2027 2032 B-clinical_variable
creatinine 6 16 2033 2043 I-clinical_variable
≤1.5 17 21 2044 2048 O
x 22 23 2049 2050 I-upper_bound
ULN 24 27 2051 2054 I-upper_bound

Symptomatic 0 11 2055 2066 O
intrinsic 12 21 2067 2076 B-chronic_disease
lung 22 26 2077 2081 I-chronic_disease
disease 27 34 2082 2089 I-chronic_disease
or 35 37 2090 2092 O
extensive 38 47 2093 2102 O
tumor 48 53 2103 2108 B-cancer
involvement 54 65 2109 2120 I-cancer
of 66 68 2121 2123 I-cancer
the 69 72 2124 2127 I-cancer
lungs 73 78 2128 2133 I-cancer
resulting 79 88 2134 2143 O
in 89 91 2144 2146 O
dyspnea 92 99 2147 2154 B-chronic_disease
at 100 102 2155 2157 O
rest 103 107 2158 2162 O

Testing 0 7 2163 2170 O
for 8 11 2171 2174 O
LVEF 12 16 2175 2179 B-clinical_variable
is 17 19 2180 2182 O
not 20 23 2183 2186 O
required 24 32 2187 2195 O
for 33 36 2196 2199 O
pre 37 40 2200 2203 O
- 40 41 2203 2204 O
registration 41 53 2204 2216 O
, 53 54 2216 2217 O
but 55 58 2218 2221 O
patient 59 66 2222 2229 O
must 67 71 2230 2234 O
not 72 75 2235 2238 O
have 76 80 2239 2243 O
a 81 82 2244 2245 O
recent 83 89 2246 2252 O
LVEF 90 94 2253 2257 O
< 95 96 2258 2259 O
LLN 97 100 2260 2263 O
or 101 103 2264 2266 O
have 104 108 2267 2271 O
symptoms 109 117 2272 2280 O
of 118 120 2281 2283 O
congestive 121 131 2284 2294 B-chronic_disease
heart 132 137 2295 2300 I-chronic_disease
failure 138 145 2301 2308 I-chronic_disease

The 0 3 2309 2312 O
patient 4 11 2313 2320 O
must 12 16 2321 2325 O
have 17 21 2326 2330 O
completed 22 31 2331 2340 O
radiation 32 41 2341 2350 B-treatment
therapy 42 49 2351 2358 I-treatment
and 50 53 2359 2362 O
be 54 56 2363 2365 O
at 57 59 2366 2368 O
least 60 65 2369 2374 O
1 66 67 2375 2376 B-lower_bound
week 68 72 2377 2381 I-lower_bound
from 73 77 2382 2386 O
the 78 81 2387 2390 O
last 82 86 2391 2395 O
systemic 87 95 2396 2404 B-treatment
chemotherapy 96 108 2405 2417 I-treatment
administration 109 123 2418 2432 O
, 123 124 2432 2433 O
with 125 129 2434 2438 O
adequate 130 138 2439 2447 O
recovery 139 147 2448 2456 O
of 148 150 2457 2459 O
bone 151 155 2460 2464 O
marrow 156 162 2465 2471 O
and 163 166 2472 2475 O
organ 167 172 2476 2481 O
functions 173 182 2482 2491 O
, 182 183 2491 2492 O
before 184 190 2493 2499 O
starting 191 199 2500 2508 O
neratinib 200 209 2509 2518 B-treatment

The 0 3 2519 2522 O
washout 4 11 2523 2530 O
period 12 18 2531 2537 O
must 19 23 2538 2542 O
have 24 28 2543 2547 O
been 29 33 2548 2552 O
completed 34 43 2553 2562 O
prior 44 49 2563 2568 O
to 50 52 2569 2571 O
the 53 56 2572 2575 O
start 57 62 2576 2581 O
of 63 65 2582 2584 O
neratinib 66 75 2585 2594 B-treatment
if 76 78 2595 2597 O
the 79 82 2598 2601 O
patient 83 90 2602 2609 O
was 91 94 2610 2613 O
taking 95 101 2614 2620 O
any 102 105 2621 2624 O
of 106 108 2625 2627 O
these 109 114 2628 2633 O
agents 115 121 2634 2640 O

There 0 5 2641 2646 O
is 6 8 2647 2649 O
no 9 11 2650 2652 O
limitation 12 22 2653 2663 O
on 23 25 2664 2666 O
the 26 29 2667 2670 O
number 30 36 2671 2677 O
of 37 39 2678 2680 O
prior 40 45 2681 2686 O
lines 46 51 2687 2692 O
of 52 54 2693 2695 O
systemic 55 63 2696 2704 B-treatment
therapy 64 71 2705 2712 I-treatment

To 0 2 2713 2715 O
be 3 5 2716 2718 O
eligible 6 14 2719 2727 O
for 15 18 2728 2731 O
the 19 22 2732 2735 O
Part 23 27 2736 2740 O
II 28 30 2741 2743 O
fulvestrant 31 42 2744 2755 B-treatment
- 42 43 2755 2756 O
naïve 43 48 2756 2761 O
ER+ 49 52 2762 2765 O
cohort 53 59 2766 2772 O
, 59 60 2772 2773 O
prior 61 66 2774 2779 B-treatment
treatment 67 76 2780 2789 I-treatment
with 77 81 2790 2794 I-treatment
fulvestrant 82 93 2795 2806 I-treatment
is 94 96 2807 2809 O
not 97 100 2810 2813 O
allowed 101 108 2814 2821 O

To 0 2 2822 2824 O
be 3 5 2825 2827 O
eligible 6 14 2828 2836 O
for 15 18 2837 2840 O
the 19 22 2841 2844 O
Part 23 27 2845 2849 O
II 28 30 2850 2852 O
fulvestrant 31 42 2853 2864 B-treatment
- 42 43 2864 2865 O
treated 43 50 2865 2872 O
ER+ 51 54 2873 2876 O
cohort 55 61 2877 2883 O
, 61 62 2883 2884 O
prior 63 68 2885 2890 O
disease 69 76 2891 2898 O
progression 77 88 2899 2910 O
on 89 91 2911 2913 O
fulvestrant 92 103 2914 2925 O
is 104 106 2926 2928 O
required 107 115 2929 2937 O

Total 0 5 2938 2943 O
bilirubin 6 15 2944 2953 B-clinical_variable
≤1.5 16 20 2954 2958 O
x 21 22 2959 2960 I-upper_bound
ULN 23 26 2961 2964 I-upper_bound

Total 0 5 2965 2970 B-clinical_variable
bilirubin 6 15 2971 2980 I-clinical_variable
≤1.5 16 20 2981 2985 O
× 21 22 2986 2987 I-upper_bound
ULN 23 26 2988 2991 I-upper_bound

Tumor 0 5 2992 2997 B-cancer
tissue 6 12 2998 3004 O
tested 13 19 3005 3011 O
positive 20 28 3012 3020 O
for 29 32 3021 3024 O
HER2 33 37 3025 3029 B-cancer
mutation 38 46 3030 3038 I-cancer

Uncontrolled 0 12 3039 3051 O
intercurrent 13 25 3052 3064 O
illness 26 33 3065 3072 O
including 34 43 3073 3082 O
, 43 44 3082 3083 O
but 45 48 3084 3087 O
not 49 52 3088 3091 O
limited 53 60 3092 3099 O
to 61 63 3100 3102 O
, 63 64 3102 3103 O
ongoing 65 72 3104 3111 O
or 73 75 3112 3114 O
active 76 82 3115 3121 B-chronic_disease
infection 83 92 3122 3131 I-chronic_disease
symptomatic 93 104 3132 3143 O
congestive 105 115 3144 3154 B-chronic_disease
heart 116 121 3155 3160 I-chronic_disease
failure 122 129 3161 3168 I-chronic_disease
, 129 130 3168 3169 O
unstable 131 139 3170 3178 B-chronic_disease
angina 140 146 3179 3185 I-chronic_disease
pectoris 147 155 3186 3194 I-chronic_disease
, 155 156 3194 3195 O
cardiac 157 164 3196 3203 B-chronic_disease
arrhythmia 165 175 3204 3214 I-chronic_disease
, 175 176 3214 3215 O
or 177 179 3216 3218 O
psychiatric 180 191 3219 3230 B-chronic_disease
illness 192 199 3231 3238 I-chronic_disease
/ 199 200 3238 3239 I-chronic_disease
social 200 206 3239 3245 I-chronic_disease
situations 207 217 3246 3256 I-chronic_disease
that 218 222 3257 3261 O
would 223 228 3262 3267 O
limit 229 234 3268 3273 O
compliance 235 245 3274 3284 O
with 246 250 3285 3289 O
study 251 256 3290 3295 O
requirements 257 269 3296 3308 O

Uncontrolled 0 12 3309 3321 O
intercurrent 13 25 3322 3334 B-chronic_disease
illness 26 33 3335 3342 I-chronic_disease
including 34 43 3343 3352 O
, 43 44 3352 3353 O
but 45 48 3354 3357 O
not 49 52 3358 3361 O
limited 53 60 3362 3369 O
to 61 63 3370 3372 O
, 63 64 3372 3373 O
ongoing 65 72 3374 3381 O
or 73 75 3382 3384 O
active 76 82 3385 3391 B-chronic_disease
infection 83 92 3392 3401 I-chronic_disease
, 92 93 3401 3402 O
unstable 94 102 3403 3411 B-chronic_disease
angina 103 109 3412 3418 I-chronic_disease
pectoris 110 118 3419 3427 I-chronic_disease
, 118 119 3427 3428 O
cardiac 120 127 3429 3436 B-chronic_disease
arrhythmia 128 138 3437 3447 I-chronic_disease
, 138 139 3447 3448 O
or 140 142 3449 3451 O
psychiatric 143 154 3452 3463 B-chronic_disease
illness 155 162 3464 3471 I-chronic_disease
/ 162 163 3471 3472 I-chronic_disease
social 163 169 3472 3478 I-chronic_disease
situations 170 180 3479 3489 I-chronic_disease
that 181 185 3490 3494 O
would 186 191 3495 3500 O
limit 192 197 3501 3506 O
compliance 198 208 3507 3517 O
with 209 213 3518 3522 O
study 214 219 3523 3528 O
requirements 220 232 3529 3541 O

Women 0 5 3542 3547 B-gender
of 6 8 3548 3550 O
childbearing 9 21 3551 3563 O
potential 22 31 3564 3573 O

men 0 3 3574 3577 B-gender

must 0 4 3578 3582 O
agree 5 10 3583 3588 B-contraception_consent
to 11 13 3589 3591 I-contraception_consent
use 14 17 3592 3595 I-contraception_consent
adequate 18 26 3596 3604 I-contraception_consent
contraception 27 40 3605 3618 I-contraception_consent
( 41 42 3619 3620 O
hormonal 42 50 3620 3628 B-contraception_consent
or 51 53 3629 3631 I-contraception_consent
barrier 54 61 3632 3639 I-contraception_consent
method 62 68 3640 3646 I-contraception_consent
of 69 71 3647 3649 I-contraception_consent
birth 72 77 3650 3655 I-contraception_consent
control 78 85 3656 3663 I-contraception_consent
, 85 86 3663 3664 O
abstinence 87 97 3665 3675 B-contraception_consent
) 97 98 3675 3676 O
prior 99 104 3677 3682 O
to 105 107 3683 3685 O
study 108 113 3686 3691 O
entry 114 119 3692 3697 O
and 120 123 3698 3701 O
for 124 127 3702 3705 O
the 128 131 3706 3709 O
duration 132 140 3710 3718 O
of 141 143 3719 3721 O
study 144 149 3722 3727 O
participation 150 163 3728 3741 O

